Kaposi's sarcoma of right lung
ICD-10 C46.51 is a billable code used to indicate a diagnosis of kaposi's sarcoma of right lung.
Kaposi's sarcoma (KS) is a vascular tumor associated with human herpesvirus 8 (HHV-8) infection, commonly seen in immunocompromised individuals, particularly those with HIV/AIDS. It can manifest in various forms, including cutaneous, lymphatic, and visceral involvement. When KS affects the lungs, it can lead to respiratory symptoms such as cough, hemoptysis, and dyspnea. The right lung is often involved due to anatomical and hemodynamic factors. Diagnosis typically involves imaging studies, such as CT scans, and histopathological examination of lung biopsies. Treatment options include antiretroviral therapy (ART) for HIV management, chemotherapy (e.g., liposomal doxorubicin), and localized therapies such as radiation for symptomatic relief. The prognosis varies based on the extent of disease and response to treatment, with early intervention being crucial for improving outcomes.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Patients presenting with respiratory symptoms and a known history of HIV.
Ensure accurate staging and treatment response documentation.
Documentation of HIV viral load, CD4 counts, and treatment history.
Patients with opportunistic infections and malignancies related to HIV.
Linking KS to HIV status is crucial for accurate coding.
Used for patients receiving chemotherapy for KS.
Document the type of chemotherapy and patient response.
Oncology specialists must ensure accurate coding of treatment modalities.
Kaposi's sarcoma is primarily caused by infection with human herpesvirus 8 (HHV-8), particularly in immunocompromised individuals such as those with HIV/AIDS.
